However, ACBD3 expression is decreased in the metastatic lesions of several cancer types, including NSCLC (Fig. 5A and Fig. S5A and B), a trend not observed in PI4KB expression levels (Fig. 5B). This evidence concerns the gene ACBD3 and non-small cell lung carcinoma.